Vibrio vulnificus is a halophilic, gram-negative bacterium that has recently become notorious for causing both serious wound infections and fatal septicemia in humans, particularly in certain underlying diseases (27, 43) . Primary septicemia may be acquired after consumption of seafoods containing this organism, with mortality exceeding 50%. Infections are associated with exposure of wounds to seawater, with a mortality rate of about 25% (2, 5, 17) . Over the last decade, there has been a dramatic increase in the number of cases due to V. vulnificus infection in the southern part of Taiwan (6).
Vibrio vulnificus is a halophilic, gram-negative bacterium that has recently become notorious for causing both serious wound infections and fatal septicemia in humans, particularly in certain underlying diseases (27, 43) . Primary septicemia may be acquired after consumption of seafoods containing this organism, with mortality exceeding 50%. Infections are associated with exposure of wounds to seawater, with a mortality rate of about 25% (2, 5, 17) . Over the last decade, there has been a dramatic increase in the number of cases due to V. vulnificus infection in the southern part of Taiwan (6) .
A variety of factors have been proposed as possible virulence determinants for V. vulnificus (13, 18, 25, 36, 37, 41) . Among these factors, hemolysin is known to be cytotoxic to Chinese hamster ovary (CHO) cells and to disrupt the membranes of various mammalian erythrocytes (19) . It also has the ability to enhance vascular permeability and is lethal to mice (13) . However, studies comparing the amount of hemolysin production and the virulence of V. vulnificus have yielded contradictory results. Both Oliver et al. (28) and Morris et al. (26) observed a lack of correlation between virulence and hemolysin production; also, Massad et al. (23) reported that mutants deficient in the production of hemolysin were still virulent for mice.
A gene (vvhA) encoding hemolysin with potent cytolytic activity has been cloned and sequenced (51) , and regions of this gene showed homology to the structural gene for the Vibrio cholerae El Tor hemolysin (29) . Our laboratory has been interested in the virulence mechanisms responsible for the pathogenicity of V. vulnificus for humans. The cloning and characterization of the gene (empV) encoding the V. vulnificus CKM-1 extracellular metalloprotease has been described elsewhere (7) . In a further study of the virulence factors of clinically isolated V. vulnificus, we also found that most strains, including strain CKM-1, exhibited a clear hemolytic zone after cultivation on blood agar plates containing rabbit erythrocytes but showed an ambiguous green-brown color after cultivation on blood agar plates containing human or sheep erythrocytes. In this study, we describe the cloning and expression of a DNA fragment from V. vulnificus which is able to induce hemolytic activity and color production in Escherichia coli.
MATERIALS AND METHODS
Bacterial strains and plasmids. The bacteria used in this study include V. vulnificus CKM-1, 40 V. vulnificus strains, 8 Aeromonas hydrophila strains, 4 Pseudomonas aeruginosa strains, 5 Staphylococcus aureus strains, and 3 Klebsiella pneumoniae strains, all isolated from the blood or stool culture of patients at the National Cheng Kung University Hospital. E. coli JA221 (1), JM109 (52), XL1B (Stratagene), and the minicell-producing strain p678-54 were used as transformation hosts. The clinical bacterial isolates and E. coli were grown in LuriaBertani (LB) medium (33) at 28 and 37°C, respectively. Recombinant E. coli cells were evaluated for hemolytic phenotypes by using tryptic soy agar containing 5% human or sheep erythrocytes. Ampicillin (50 g ml Ϫ1 ) was added when appropriate for selection. Color production (browning) in strains and clones was examined by assay after cultivation on LB agar plates or PIG agar plates, which are LB agar plates supplemented with 0.025% ferric PPi, 0.04% cysteine, and 4 mM tyrosine (47) . When necessary, the medium was supplemented with IPTG (isopropyl-␤-D-thiogalactopyranoside) to a final concentration of 1 mM. Ampicillin, ferric PPi, cysteine, and tyrosine were purchased from the Sigma Chemical Co. (St. Louis, Mo.). Plasmid pBR322 (3) was used in cloning experiments; plasmids pUC18 and pUC19 (44) were used in the subcloning experiments. A 1.3-kb AccI-BstXI fragment was subcloned into the AccI and BstXI site of the high-expression vector pBC (Stratagene) to produce plasmid pBCV. This placed the initiation codon of VllY at an appropriate distance from the T7 promoter to allow high-level expression of the VllY protein.
Construction and screening of the genomic library. All DNA manipulations were carried out in accordance with the manufacturers' instructions as described by Sambrook et al. (33) . The preparation of the genomic library containing V. vulnificus CKM-1 genomic DNA in the vector pBR322 has been described previously (4) . The gene bank was used to transform E. coli JA221, and transformants were screened on blood agar plates. After 48 h of incubation at 37°C, the colonies that had clear zones around them were isolated and further screened on the PIG agar plates. The colonies that exhibited brown color were collected and subjected to advanced analysis at the molecular level.
Minicell isolation and labelling of proteins. Cells of E. coli p678-54 (F Ϫ thr leu thi supE lacY fhuA gal mal xyl mtl) were transformed with the plasmids. Minicells were prepared in sucrose density gradients, and proteins were labelled with L-[ 35 S]methionine (Ͼ1,200 Ci/mmol; Amersham) according to the method of Dougan and Kehoe (9) . After being labelled, components in cell lysates of the minicells were separated by 0.1% sodium dodecyl sulfate (SDS)-12% polyacrylamide gel electrophoresis (PAGE) (20) . The gels were dried and exposed for 2 days to X-ray film at Ϫ70°C and developed by using Kodak (Rochester, N.Y.) developer and fixer.
DNA sequencing and sequence analysis. All sequences were determined on denatured double-stranded DNA templates by the dideoxy chain-termination method (34) ) (New England Nuclear). Universal and reverse primers were used to obtain the initial sequences within the inserts, and then specific primers for the sequences within the inserts were generated. Conditions for DNA sequencing were as described in the Sequenase brochure (U.S. Biochemicals). Denaturing 6% PAGE at 60 W was used to separate the reaction products. The gels were exposed to X-ray film (Omat-AR; Kodak) overnight. DNA was sequenced in both directions. In some cases, dITP was used in place of dGTP for a more reliable reading through regions of high GϩC content. Sequence analysis was carried out with the PC/GENE software package (Intelligenetics).
Cellular fractionation and N-terminal amino acid sequence analysis. To express the vllY gene in E. coli, a DNA fragment containing the open reading frame (ORF) of vllY was inserted into pUC and pBC vectors. The E. coli cells containing plasmid DNA were collected, and cellular fractionation was performed as described by Chang et al. (4) . The periplasmic proteins remained in the supernatant when the cells were pelleted. The cell pellets were lysed by five cycles of freezing-thawing. After removal of unlysed cells, the total membrane (pellet) and cytoplasmic (supernatant) fractions were collected by centrifugation (15,000 ϫ g, 30 min). The proteins present in the various fractions of spheroplasts were separated by SDS-PAGE (20) . The proteins separated on the gels were electroblotted onto a polyvinylidene difluoride membrane. After being visualized with Coomassie brilliant blue R250 stain, the membrane was cut into pieces containing the 40-kDa proteins corresponding to VllY. The membrane pieces were directly applied to a protein sequencer (model 477A; Applied Biosystems, Foster City, Calif.) for amino-terminal amino acid sequence analysis. The deduced amino acid sequence of VllY was analyzed by using BLAST E-mail searches of the databases at the National Center for Biotechnology Information. Multiple alignments of the amino acid sequences among the homologous proteins were performed with the CLUSTAL multiple sequence alignment program (14) .
Hemolytic activity assay. Ten-milliliter volumes of sheep erythrocytes were each washed twice in 0.015 M Tris-HCl (pH 8.0)-0.17M NaCl and resuspended to 2.25% in the buffer. A sample (0.5 ml) of this solution was added to 1 ml of enzyme preparation. The mixtures were incubated at 37°C for 45 min and then centrifuged at 2,500 rpm (MSE Microcentaur; Serlabo, Paris, France) for 2 min. The amount of hemoglobin released was estimated by measuring the absorbance of the supernatant at 540 nm. Each assay was run two or three times (42) .
PCR. PCR was performed with a model PE 2400 automated thermocycler with MicroAm tubes (Perkin-Elmer Cetus, Norwalk, Conn.). The reaction was carried out in a 50-l volume containing 5 l of 10ϫ buffer (supplied with Taq), 20 pmol of each primer, 1 mM deoxynucleoside triphosphate, 2.5 U of Taq DNA polymerase (Boehringer), and 1 l of bacterial lysate or 100 ng of genomic DNA. About 1 to 10 ng of plasmid DNA or insert DNA was used. PCR conditions were as follows: 30 cycles at 94°C for 1.0 min, 52°C for 1.0 min, and 72°C for 1.0 min. A final extension step of 10 min at 72°C was included. Chromosomal DNAs from several clinically isolated strains, including V. vulnificus, A. hydrophila, P. aeruginosa, S. aureus, and K. pneumoniae, were used as templates. Two oligodeoxyribonucleotides, 5Ј-GCAGTCTAGAAGGAGGAATTCCTG and 5Ј-GCGCTG GTCTCGAGAAGTGAA, were designed for the operon of vllY. The other oligodeoxyribonucleotides, 5Ј-CCGCGGTACAGGTTGGCGC and 5Ј-CGCC ACCCACTTTCGGGCC, which have been used to amplify a specific 519-bp region of the hemolysin previously shown to be unique to V. vulnificus (15) , were used as PCR primers.
Southern hybridization. Chromosomal DNA was digested with the restriction endonuclease SmaI, separated by agarose gel electrophoresis, and transferred to Zeta-probe GT membranes (Bio-Rad Laboratories, Richmond, Calif.). An AccIBstXI DNA fragment cut from plasmid pVK5 served as the probe after being labelled with [␣-32 P]dCTP (Ͼ3,000 Ci/mmol; Amersham) by using the Prime-aGene labeling system (Promega, Madison, Wis.). Membranes were hybridized at 60°C for 16 h, exposed to X-ray film at Ϫ70°C for 2 days, and developed with Kodak developer and fixer as recommended by the manufacturer.
Nucleotide sequence accession number. The nucleotide sequence of the hemolysin gene vllY cloned from V. vulnificus CKM-1 has been assigned GenBank accession no. U97357.
RESULTS
Cloning of the vllY gene. To clone the determinants responsible for the hemolytic phenotypes of V. vulnificus, a genomic library derived from V. vulnificus CKM-1 was used to transform E. coli JA221. Transformed E. coli cells were screened on blood agar plates to select hemolytic clones. Seven clones which displayed hemolytic phenotypes on blood agar plates were isolated from an initial screen of approximately 6,000 E. coli transformants. Four of these clones exhibited a clear zone of hemolysis around the colonies, while the remaining three clones exhibited a zone of hemolysis and were able to display green-brown color after incubation at 37°C for 2 days. A gene (vvhA) which codes for the V. vulnificus hemolysin that has cytolytic activity has been cloned and sequenced (48, 51) . To test whether the vvhA-specific DNA sequence was present in these seven hemolytic phenotype clones, plasmid DNA was isolated from the clones and hybridized with synthetic DNA probe, which was designed according to the vvhA sequence of V. vulnificus EDL-174 (51). The results showed that four clones, which exhibited clear zones on blood agar plates, were positive and hybridized with the synthetic probe; the remaining three clones showed negative reactions (data not shown).
To further investigate the genes encoding proteins responsible for hemolysis and color production, plasmid DNA was isolated from the three negative clones and subjected to restriction endonuclease mapping. All three clones contained an identical 4.5-kb fragment. When this fragment was recloned into pUC18 and pUC19 (pVK1 and pVK4, respectively), both plasmids coded for the protein which confers hemolysis and color production on recombinant E. coli JM109. This indicated that the genes encoding the two phenotypes seem to be transcribed from a single promoter. To determine the approximate location of the gene responsible for the two phenotypes in the cloned DNA fragment, several subclones were generated from pVK4 and analyzed for the two properties. Subcloning revealed that a 1.3-kb AccI-NlaIV fragment was sufficient to produce the two properties in E. coli JM109 (Fig. 1) .
Detection of the VllY protein in minicells. To identify the gene product encoded by pVK5 (Fig. 1) , the E. coli minicell- producing strain (p678-54), which permits specific labelling of the plasmid-encoded proteins, was transformed with plasmids pVK5 and pUC18 and minicells were prepared and labelled with L-[ 35 S]methionine. A unique heavily labelled polypeptide of approximately 40 kDa was found in minicells carrying pVK5 (Fig. 2) , and no such labelled polypeptide was observed in minicells carrying pUC18. Synthesis of all other identifiable proteins detected was conducted by the vector plasmid. The fact that only one polypeptide unique to pVK5 was observed by minicell analysis indicated that the vllY gene, encoding a protein of about 40 kDa, is responsible for hemolysis and color production in recombinant E. coli cells.
Nucleotide sequence of vllY. The nucleotide sequence of vllY and its flanking regions was determined on both strands (Fig.  3) . The sequence revealed that an ORF of 1,071 bp encodes a polypeptide of 357 amino acids with a molecular mass of 40,223 Da, which is in agreement with the size of the protein expressed in the minicell labelling experiments. A possible ribosomal binding site (Shine-Dalgarno sequence) (40), AGGA, was found 7 bp upstream from the presumptive start codon, ATG. Although we have not yet determined the promoter sequences that function in E. coli, sequences homologous to E. coli Ϫ35 and Ϫ10 promoter consensus sequences (24) were observed 73 bp upstream from the start codon. Furthermore, an AϩT-rich region, which had been shown to be involved in transcription regulation in E. coli (30) , was found immediately upstream from the consensus sequences. At a point 84 bp downstream from the stop codon, there was a palindromic sequence between nucleotides 1,259 and 1,288. This structure would be expected to function as a transcriptional terminator. The GϩC content of the coding region for VllY was 47.3%, which is nearly identical to those of ␤-Nacetylhexosaminidase (47% [38] ) and cytolysin (48% [51] ) and a little lower than that for the fur gene (50.3% [22] ). The codon usage frequency in the vllY gene is similar to the pattern for the aforementioned genes of this species (data not shown).
Gene expression and localization of the VllY protein in E. coli transformants. E. coli JA221 cells containing plasmid pVK5 did not express the vllY gene efficiently; the vllY gene was placed directly under the control of the strong T7 promoter. The resulting plasmid was designated pBCV. Expression of the vllY gene upon induction with IPTG in E. coli XL1B cells containing plasmid pBCV is shown in Fig. 4 . No major polypeptides could be detected in E. coli cells carrying only the pBC vector or in uninduced cultures. The overexpressed vllY gene product migrated as a 40-kDa polypeptide, which agreed well with the value calculated from minicell analysis and from the putative amino acid sequence. To determine the cellular location of the gene product, E. coli cells carrying pBCV in induced culture were grown to the exponential phase and fractionated. The hemolytic activity of VllY was determined in the cell-free supernatant and the periplasmic and cytoplasmic fractions. Marker enzymes, E. coli ␤-lactamase and ␤-galactosidase, were also assayed for each fraction to monitor cell lysis and the efficiency of cell fractionation. The results showed that 50% of the hemolytic activity and 85% of ␤-lactamase activity occurred in the periplasmic fraction and 45% of the hemolytic activity and 90% of ␤-galactosidase activity were found in the cytoplasmic fraction. No significant ␤-lactamase or ␤-galactosidase activity was detected in the culture supernatants (data not shown).
No significant cell lysis could be observed in the cytoplasmic fraction, where ␤-galactosidase activity was primarily found, while ␤-lactamase activity was located in the periplasm. Thus, the distribution of VllY in both the periplasmic and the cytoplasmic fractions should reflect the true destination of the enzyme. The distribution of VllY in both the periplasmic and the cytoplasmic fractions was also observed by SDS-PAGE (Fig. 4) . From these measurements, it is apparent that VllY is capable of being processed in the periplasm in E. coli. Furthermore, the N-terminal sequence of the VllY protein obtained from the periplasmic fraction was determined to be Val-Asp-Ala-Ile-Asn-Pro-Leu-Gly-Thr-Asp-Gly, which was completely identical to the beginning of the amino acid sequence deduced from the DNA sequence, except that the N-terminal methionine residue was not present in the intact protein.
Alignment of VllY amino acid sequences with other proteins. Analysis of the deduced amino acid sequence of VllY for homology to other sequences in the GenBank database, using BLAST searches at the National Center for Biotechnology Information, revealed high degrees of similarity (76.1%) and identity (57.2%) to the Lly protein of Legionella pneumophila (47) without large gaps or insertions. The enzyme also showed high levels of similarity to the MelA protein of Shewanella colwelliana (63.7% similarity and 42.2% identity) (11) and those of HPPD (4-hydroxyphenylpyruvate dioxygenase) family proteins from various organisms (10, 12, 16, 21, 31, 35, 50) . A multiple alignment of their amino acid sequences (Fig. 5) shows relatively poor N-terminal homology and a greater number of conserved regions in C-terminal parts of the proteins.
Conservation of the vllY gene among clinical V. vulnificus isolates. Because most clinically isolated V. vulnificus strains exhibited an ambiguous green-brown color after cultivation on blood agar plates containing human or sheep erythrocytes, we examined the possibility that the vllY-specific DNA sequence might be conserved. Two approaches were used to determine the presence of vllY-specific DNA sequences in the chromosomal DNAs from clinically isolated V. vulnificus strains. Southern blotting analysis of SmaI-digested chromosomal DNAs of several V. vulnificus strains (including CKM-1), probed with a 1.3-kb DNA fragment (which contains the entire 1,071-bp vllY operon), showed that similar SmaI DNA fragment patterns were conserved among the V. vulnificus strains (Fig. 7) . No significant DNA band was seen when chromosomal DNA of A. hydrophila, P. aeruginosa, S. aureus, or K. pneumoniae was used as the template (data not shown).
DISCUSSION
This paper describes the molecular cloning, sequencing, and identification of a V. vulnificus CKM-1 gene encoding a protein that induces hemolysis and color production in recombinant E. coli strains. The protein is encoded by an ORF of 1,071 bp coding for 357 amino acids with a predicted molecular mass of 40,223 Da and an estimated pI of 5.02. The amino acid sequence of the polypeptide showed strong similarity to that of legiolysin (Lly) of L. pneumophila, which causes hemolysis and pigment production in recombinant E. coli cells. We have therefore designated this gene vllY, for VllY protein of V. vulnificus CKM-1. No such protein has been described for the species V. vulnificus, and our results document for the first time the presence of a vllY gene in this species.
The extensive homology between V. vulnificus VllY and L. pneumophila Lly is an interesting finding. The Lly protein of L. pneumophila has been shown to confer the properties of hemolytic activity in human erythrocytes and pigment production when expressed by recombinant E. coli carrying an lly gene. Like the Lly protein, VllY also produces these two phenotypes of recombinant E. coli. It has been reported that the pigment produced by Legionella resembles melanin (46) and that the pigment production of various organisms is enhanced when the culture medium is supplemented with L-tyrosine. Likewise, the browning of the culture medium by recombinant E. coli harboring the vllY gene was observed after 2 days in culture at 37°C in both LB and PIG liquid media and was increased by the addition of tyrosine (data not shown). However, it has been reported that the Lly protein additionally confers the phenotypic characteristic of fluoresence, whereas this distinctive property was not observed in recombinant E. coli carrying a vllY gene when the cells were illuminated by a long-wave UV lamp in the dark. Some differences in the sequences of the two proteins may be responsible for the third phenotype produced by the Lly protein.
A BLAST search revealed that the VllY protein is also homologous to both prokaryotic and eukaryotic forms of the HPPD family proteins, including the related F antigen, as well as to S. cowelliana MelA, which has been identified as an HPPD-like protein. The C-terminal amino acid sequence is thought to be highly conserved in the HPPD family proteins. The multiple alignment of amino acid sequences shown in Fig.  5 revealed that the deduced structure of the V. vulnificus VllY presented here also contained these highly conserved sequence motifs of HPPD proteins, suggesting that VllY is an HPPDlike protein. The fact that pigment formation in vllY-positive E. coli is enhanced in the presence of tyrosine also suggests that VllY and 4-hydroxyphenylpyruvate dioxygenase have similar functions in catalyzing the formation of homogentisate from 4-hydroxypyruvate, a product which is formed following transamination of L-tyrosine (8) . The high degree of homology in the C-terminal part of the HPPD family proteins suggests that this part of the protein is important to enzymatic function. Recently, it has been reported that several histidine and tyrosine residues are potential metal-binding sites in the Pseudomonas HPPD protein (31) , and some of those residues seem to be highly conserved among the HPPD family proteins, as shown in Fig. 5 .
Cellular fractionation studies revealed that VllY is present in both the periplasmic and cytoplasmic spaces of E. coli, indicating that VllY protein can traverse the inner membrane without the need for V. vulnificus-specific factors. However, an examination of the putative amino-terminal sequence of the VllY protein revealed no conventional signal sequence, such as those seen in a number of other secreted proteins characterized in bacteria (45) . Furthermore, the N-terminal amino acid sequence obtained from the periplasmic fractions of E. coli cells carrying the vllY gene shows that only the initiating methionine is processed. Secretion of the VllY protein into the periplasmic space of E. coli is, therefore, independent of a signal sequence. It is speculated that VllY is secreted into the periplasmic space of E. coli through a novel secretion mechanism, which will be addressed in subsequent investigations.
Under stringent hybridization conditions, the vllY gene hybridized with DNA from all of our clinical V. vulnificus isolates but not with DNA isolated from A. hydrophila, P. aeruginosa, S. aureus, or K. pneumoniae. It should be noted that the V. vulnificus strains that we tested were isolated from several patients over an extended time in the southern part of Taiwan. V. vulnificus elaborates cytotoxin-hemolysin, and DNA probes targeted to the relevant gene of V. vulnificus have been used for species identification (15) . To elucidate whether the cytotoxin-hemolysin gene is unique to our clinical V. vulnificus isolates, a pair of PCR primers designed to amplify a 519-bp region within an ORF of a HincII fragment encoding the cytotoxin-hemolysin gene were constructed and PCR experiments were performed according to the method described by Hill et al. (15) . The results revealed that the 519-bp DNA fragment could be obtained when DNA from any of our clinical V. vulnificus isolates was used as the template of the PCR but not when DNA isolated from other bacteria, including A. hydrophila, P. aeruginosa, S. aureus, and K. pneumoniae, was used (data not shown). Furthermore, the Southern blotting results agreed with those of PCR (data not shown). From the results of both Southern analysis and PCR, we concluded that both the vvhA and vllY genes are unique to our clinical V. vulnificus isolates and all our clinical V. vulnificus isolates possess at least two different types of hemolytic proteins: cytotoxin-hemolysin protein and one that causes browning of the medium. However, data concerning the inactivation of the V. vulnificus EDL-174 hemolysin gene in the chromosomal DNA by transposon mutagenesis or marker exchange techniques, which results in a nonhemolytic phenotype (49) , contrast with the results presented here. Two possible reasons for the discrepancy are that VllY is not detectable with the blood agar plates containing rabbit erythrocytes used by the authors and that V. vulnificus EDL-174 is a VllY-negative strain. At present, we are uncertain whether the vllY gene exists in all clinical and environmental isolates. It will be of interest to investigate whether the vllY gene can provide a useful general DNA probe for clinical or environmental V. vulnificus isolated from various geographic locations.
The precise role of the vllY gene in V. vulnificus is unclear. Its presence in all our clinical V. vulnificus isolates suggests that it may have a role in the pathogenicity of V. vulnificus. Recently, it has been reported that the cloned lly gene conferred increased resistance to light in recombinant L. pneumophila and E. coli K-12, suggesting that the Lly of L. pneumophila might be important for the survival of L. pneumophila stressed by light (39) . We have cloned the vllY gene from V. vulnificus and have begun preliminary characterization of its protein product. Further study with genetic modifications for functional analyses and serological evaluation may help to elucidate whether the vllY gene is responsible for the survival of V. vulnificus and the possibility that VllY protein may also be a virulence determinant in the pathogenesis of V. vulnificus.
